Novartis AG
NOVEL HETEROARYL BUTANOIC ACID DERIVATIVES
Last updated:
Abstract:
The present invention describes novel heteroaryl butanoic acid derivatives that are good drug candidates especially with regard to leukotriene A4 hydrolase (LTA4H). The present invention also relates to pharmaceutical compositions comprising said novel heteroaryl butanoic acid derivatives, methods of using said compounds in the treatment of various diseases and disorders, and processes for preparing the said novel compounds.
Status:
Application
Type:
Utility
Filling date:
1 Jul 2021
Issue date:
4 Nov 2021